Zakaria Vahabzadeh

6PUBLICATIONS
9CO-AUTHORS
Te ariā o ngā tauira panoni hauora o te Māori (Māori theory of change models for health)Nutrigenomics and personalised nutritionNanomaterialsHaematological tumoursVision science
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 02, 2025
TMAO promotes metabolic dysfunction-associated fatty liver disease (MAFLD) development through long-non coding RNA- highly upregulated liver cancer (HULC).

Mohammad Moradzad, Mohammad Raman Moloudi, Alina Abdollahi

|Jan 13, 2025
Gut microbiota dysbiosis contributes to choline unavailability and NAFLD development.

Mohammad Moradzad, Dana Ghaderi, Mohammad Abdi

|Mar 27, 2024
Trimethylamine-N-oxide, a New Risk Factor for Non-alcoholic Fatty Liver Disease Changes the Expression of miRNA-34a, and miRNA-122 in the Fatty Liver Cell Model.

Zhila Bahramirad, Mohammad Raman Moloudi, Mohammad Moradzad

|Mar 09, 2024
CTLA-4 Blockade of Natural Killer Cells Increases Cytotoxicity against Acute Lymphoid Leukaemia Cells Neda.

Neda Parvini, Mohammad Esmaeil Akbari, Amir Ali Hamidieh

|Aug 09, 2022
Protective Effect of Curcuma Extract in an Ex Vivo Model of Retinal Degeneration via Antioxidant Activity and Targeting the SUMOylation.

Kambiz Hassanzadeh, Zakaria Vahabzadeh, Lucia Bucarello

|Mar 29, 2022
Possible correlation between high circulatory levels of trimethylamine-N-oxide and 2177G>C polymorphisms of hepatic flavin containing monooxygenase 3 in Kurdish Population with non-alcoholic fatty liver disease.

Mohammad Moradzad, Mohammad Abdi, Farshad Sheikh Esmaeili

Pageof 1

Frequent Collaborators

1 joint publications

Kambiz Hassanzadeh

1 joint publications

Lucia Bucarello

1 joint publications

Jessica Dragotto

1 joint publications

Massimo Corbo